The Patent Finder

Vegenics Pty Limited

Also on record
Records under this name other than the patents Vegenics Pty Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Vegenics Pty Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,274,503Methods of Using VEGF-C Biomarkers for Age-Related Macular Degeneration (AMD) Diagnosis
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,209,444Treatment for age-related macular degeneration (AMD) and pathogenic ocular neovascularization
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,940,695Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Formerly held
Term ended
Term ended Nov 10, 2026 · Medium confidence
Term endedTerm ended Nov 10, 2026Medium confidence
US 7,846,437Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
Term ended
Term ended Mar 7, 2025 · USPTO record
Term endedTerm ended Mar 7, 2025USPTO record
US 7,534,572Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
Lapsed on the fee record
Ended May 19, 2021 · USPTO record
Lapsed on the fee recordEnded May 19, 2021USPTO record
US 7,871,798Mammalian cells that express VEGF-D polypeptides
Term ended
Term ended Mar 24, 2019 · USPTO record
Term endedTerm ended Mar 24, 2019USPTO record
US 7,410,639Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use
Term ended
Term ended Mar 21, 2019 · USPTO record
Term endedTerm ended Mar 21, 2019USPTO record
US 7,122,654Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
Term ended
Term ended Sep 14, 2018 · USPTO record
Term endedTerm ended Sep 14, 2018USPTO record
US 6,958,147Use of VEGF-C to prevent restenosis
Lapsed on the fee record
Ended Oct 25, 2017 · USPTO record
Lapsed on the fee recordEnded Oct 25, 2017USPTO record
US 7,785,803Antibody diagnostic kits and methods of use
Term ended
Term ended Oct 10, 2017 · USPTO record
Term endedTerm ended Oct 10, 2017USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited